<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An. bras. dermatol.</journal-id>
      <journal-title-group>
        <journal-title>Anais brasileiros de dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23197216</article-id>
      <article-id pub-id-type="pmc">3699913</article-id>
      <article-id pub-id-type="doi">10.1590/S0365-05962012000600018</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Type 1 Ig-E mediated allergy to human insulin, insulin analogues and
beta-lactam antibiotics<sup><xref ref-type="fn" rid="fn01">*</xref></sup></article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Hipersensibilidade imediata a insulina humana, an&#xE1;logos de
insulina e a antibi&#xF3;ticos beta-lact&#xE2;micos</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Andrade</surname>
            <given-names>Pedro</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barros</surname>
            <given-names>Lu&#xED;sa</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gon&#xE7;alo</surname>
            <given-names>Margarida</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label>M. D. - Intern of Dermatology and Venereology - Dermatology and
Venereology Service, Teaching Hospitals of University of Coimbra (Universidade de
Coimbra, EPE) - Coimbra, Portugal</aff>
      <aff id="aff02"><label>2</label>M.D. - Specialist in Endocrinology - Hospital Assistant - Endocrinology
Service, Teaching Hospitals of University of Coimbra (Universidade de Coimbra, EPE) -
Coimbra, Portugal</aff>
      <aff id="aff03"><label>3</label>M.D. - Specialist in Dermatology and Venereology - Service Head -
Dermatology and Venereology Service, Teaching Hospitals of University of Coimbra
(Universidade de Coimbra, EPE) - Coimbra, Portugal</aff>
      <author-notes>
        <corresp id="c01"><bold>Mailing address:</bold> Pedro Andrade, Servi&#xE7;o de Dermatologia e
Venereologia - Hospitais da Universidade de Coimbra, Praceta Mota Pinto 3000-075,
Coimbra - Portugal, E-mail: <email>pedro.andrade@portugalmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2012</year>
      </pub-date>
      <volume>87</volume>
      <issue>6</issue>
      <fpage>917</fpage>
      <lpage>919</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.anaisdedermatologia.org.br">http://www.anaisdedermatologia.org.br</ext-link>
      <ext-link ext-link-type="uri" xlink:href="http://www.scielo.br/abd">http://www.scielo.br/abd</ext-link>
      <history>
        <date date-type="received">
          <day>05</day>
          <month>8</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>08</day>
          <month>11</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2012 by Anais Brasileiros de Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Insulin, a crucial therapeutic agent for diabetes mellitus, has been rarely
associated with hypersensitivity events. We present a 69-year-old type-2 diabetic
patient with urticariform lesions on the sites of subcutaneous injection of insulin.
The patient denied any known allergies, except for an unspecific cutaneous reaction
after intramuscular penicillin administration in childhood. Prick tests revealed
positive reactions to all tested human insulins and insulin analogues. Serum IgE
levels were above normal range and RAST tests were positive for human, bovine and
porcine insulins, as well as beta-lactams. Type 1 IgE-mediated allergy to insulin
analogues demands a prompt diagnosis and represents a significant therapeutic
challenge in diabetic patients.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>A insulina &#xE9; um agente indispens&#xE1;vel para o controlo da diabetes
mellitus. Os efeitos adversos da sua administra&#xE7;&#xE3;o, em particular
fen&#xF3;menos de hipersensibilidade, s&#xE3;o raros. Apresentamos um doente de
69 anos, diab&#xE9;tico do tipo 2, com epis&#xF3;dios recorrentes de
les&#xF5;es urticariformes nos locais de administra&#xE7;&#xE3;o
subcut&#xE2;nea de insulina. Negava alergias medicamentosas, &#xE0;
excep&#xE7;&#xE3;o de reac&#xE7;&#xE3;o n&#xE3;o especificada na
inf&#xE2;ncia ap&#xF3;s penicilina intramuscular. Foram realizados testes
cut&#xE2;neos por puntura (prick tests) com diversos tipos de insulina humana e
an&#xE1;logos, todos com reac&#xE7;&#xF5;es positivas, associando
eleva&#xE7;&#xE3;o dos n&#xED;veis de IgE s&#xE9;rica e provas RAST positivas
para as insulinas humana, bovina e porcina e para os antibi&#xF3;ticos
beta-lact&#xE2;micos. A alergia a an&#xE1;logos de insulina exige um
diagn&#xF3;stico precoce, originando um desafio terap&#xEA;utico importante no
doente diab&#xE9;tico.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>Diabetes mellitus, type 2</kwd>
        <kwd>Drug hypersensitivity</kwd>
        <kwd>Insulin</kwd>
        <kwd>Penicillins</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Insulin is an essential therapeutic agent for the management of <italic>diabetes
mellitus. </italic>Immediate hypersensitivity to recombinant human insulin
preparations and insulin analogues is rare and may be associated with hypersensitivity
to other molecules. </p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>We present the case of a 69-year-old male with type 2 <italic>diabetes mellitus
</italic>diagnosed at the age of 63, that due to insufficient glycemic control on oral
therapy alone and intolerance to some oral antidiabetics, was treated with premixed
insulin analogues lispro and lispro protamine (Humalog Mix 25<sup>TM</sup>) during the
previous two years. The onset of pruriginous urticariform abdominal plaques with
peripheral pale halos was observed, arising within minutes at the sites of subcutaneous
insulin administration and occasionally at distant sites, recurring at nearly every
insulin injection in the past year (<xref ref-type="fig" rid="f01">Figure 1</xref>).
Lesions regressed spontaneously in the space of a few minutes or hours. Glycemic control
was acceptable (serum glycated hemoglobin A<sub>1</sub>c levels were 53mmol/mol - 7.0% -
at presentation) and apparently unaffected by the cutaneous reaction. </p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Pruriginous urticariform abdominal plaques with peripheral pale halos arising
within minutes at the sites of abdominal subcutaneous insulin administration</p>
        </caption>
        <graphic xlink:href="abd-87-0917-g01"/>
      </fig>
      <p>The patient presented class I obesity (body mass index 31), dyslipidemia and arterial
hypertension and was regularly treated with oral atorvastatin 20mg o.d., telmisartan
80mg o.d., hydrochlorothyazide 12.5mg o.d. and triflusal 300mg o.d.. No known allergies
were reported, apart from a generalized erythematous cutaneous eruption of unclear
nature following intramuscular penicillin injection in his childhood, which justified
the avoidance of beta-lactam antibiotics ever since. </p>
      <p>The diagnosis of immediate hypersensitivity to insulin analogue lispro was therefore
suspected. Rechallenging administration of 2U of the regularly used insulin induced, in
few minutes, a new pruriginous urticariform lesion at the site of the injection (<xref ref-type="fig" rid="f02">Figure 2</xref>). </p>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Pruriginous papule with 7mm in diameter arising 20 minutes after rechallenging 2U
of Humalog Mix 25<sup>TM</sup> in the right arm</p>
        </caption>
        <graphic xlink:href="abd-87-0917-g02"/>
      </fig>
      <p>Prick tests using several different types of human insulin and insulin analogues were
performed and all of them triggered positive reactions (papule diameters &gt;3mm
after 20minutes and &gt;5mm after 60 minutes) (<xref ref-type="table" rid="t01">Table 1</xref>). Papules 5 and 7mm in diameter were observed 20 and 60 minutes after
prick test with <italic>Merck<italic/> &#xAE; </italic> histamine 10mg/ml solution
(positive control), while no reaction was induced by isotonic sodium chloride solution
(negative control). </p>
      <table-wrap id="t01" orientation="portrait" position="float">
        <label>Table 1</label>
        <caption>
          <p>Prick tests with different human insulins and insulin analogues. NC: not
considered due to local scratching</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <td rowspan="1" colspan="1">&#xA0;</td>
              <td colspan="2" rowspan="1">
                <bold>Induration (mm)</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">&#xA0;</td>
              <td rowspan="1" colspan="1">
                <bold>20 min</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>60 min</bold>
              </td>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">Sodium chloride (0.9%)</td>
              <td rowspan="1" colspan="1">0</td>
              <td rowspan="1" colspan="1">0</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Histamine (10mg/ml)</td>
              <td rowspan="1" colspan="1">5</td>
              <td rowspan="1" colspan="1">7</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Humalog Mix 25<sup>TM</sup> (Lilly)</td>
              <td rowspan="1" colspan="1">7</td>
              <td rowspan="1" colspan="1">NC</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Humulin Regular<sup>TM</sup> (Lilly)</td>
              <td rowspan="1" colspan="1">6</td>
              <td rowspan="1" colspan="1">9</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Humulin NPH<sup>TM</sup> (Lilly)</td>
              <td rowspan="1" colspan="1">4</td>
              <td rowspan="1" colspan="1">6</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Lantus<sup>TM</sup> (Sanofi-Aventis)</td>
              <td rowspan="1" colspan="1">3</td>
              <td rowspan="1" colspan="1">5</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Levemir<sup>TM</sup> (Novo Nordisk)</td>
              <td rowspan="1" colspan="1">3</td>
              <td rowspan="1" colspan="1">7</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Humulin M3<sup>TM</sup> (Lilly)</td>
              <td rowspan="1" colspan="1">5</td>
              <td rowspan="1" colspan="1">NC</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Actrapid<sup>TM</sup> (Novo Nordisk)</td>
              <td rowspan="1" colspan="1">8</td>
              <td rowspan="1" colspan="1">NC</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>Total serum IgE was three times above the normal limit (312UI/ml), with class 3
radioallergosorbent tests (RAST) for human, bovine and porcine insulins (13.2KU/L,
16.0KU/L and 14.3KU/L respectively). Interestingly, RAST for beta-lactam antibiotics
were reported as Class 2 (1.0KU/L for penicillin G, 0.94KU/L for penicillin V, 0.87KU/L
for ampicillin and 0.72KU/L for amoxycillin), and Class 0 for cefaclor (0.08KU/L). </p>
      <p>These results allowed the confirmation of type 1 IgE-mediated hypersensitivity to human
insulin and insulin analogues lispro, glargine and detemir. In addition, despite being
insufficient for clear identification of hypersensitivity to beta-lactams, results
concerning these antibiotics were considered relevant, based on the previous cutaneous
eruption following penicillin treatment and the age of the patient, which in association
with the lack of re-exposure to beta-lactams during several decades might explain the
low serum concentration of specific IgE. Even so, it is interesting to notice the
absence of cross-reactivity with cephalosporin. </p>
      <p>After evaluation by an endocrinologist, insulin therapy was suspended and the patient
began the intake of an oral anti-diabetic drug association. Cutaneous lesions did not
recur and reasonable glycemic control was achieved after three months (fasting blood
glucose levels ranging between 5,511.0mmol/L; serum glycated hemoglobin 55mmol/mol -
7.2%). As a high risk diabetic patient with several associated vascular and metabolic
comorbidities, oral therapy has been considered insufficient and the patient has been
proposed for insulin desensitization. </p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Urticaria may, in some cases, be triggered by drugs. <sup><xref ref-type="bibr" rid="r01">1</xref></sup> Immediate hypersensitivity to insulin is a rare condition among patients
suffering from type 2 <italic>diabetes mellitus</italic>, particularly after the
development of recombinant human insulins, which are clearly less immunogenic than
former animal preparations. <sup><xref ref-type="bibr" rid="r02">2</xref></sup> In most cases it presents as immediate urticariform lesions or pruritus on the
sites of the triggering injection, and in some instances also on other recent
administration sites. <sup><xref ref-type="bibr" rid="r03">3</xref></sup> Due to the risk of serious reactions such as angioedema, anaphylactic shock and
glycemic control deterioration, suspicion of insulin hypersensitivity should lead to
therapy suspension and diagnosis confirmation by complete immunologic work-up. <sup><xref ref-type="bibr" rid="r04">4</xref></sup> Management of these patients might be challenging and should involve a
multidisciplinary team. Rarely, additives such as meta-cresol, zinc or protamine,
included in commercial insulin preparations, may be the responsible allergens, and this
possibility was not excluded in the present case. <sup><xref ref-type="bibr" rid="r05">5</xref></sup>
</p>
      <p>Insulin analogues have been considered as useful alternatives for insulin
hypersensitivity patients, despite some rare demonstrations of their immunogenicity. <sup><xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r06">6</xref>,<xref ref-type="bibr" rid="r07">7</xref></sup> The present case corroborates the allergenic potential of short-acting and
long-acting insulin analogues. The associated hypersensitivity to beta-lactam
antibiotics is also noteworthy and has been previously reported in few cases of type 1
IgE-mediated insulin allergy. <sup><xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r08">8</xref>,<xref ref-type="bibr" rid="r09">9</xref></sup>
</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>Conflict of interest: None</p>
      </fn>
      <fn fn-type="other">
        <p>Financial funding: None</p>
      </fn>
      <fn id="fn01" fn-type="other">
        <p>* Study carried out at the Dermatology and Venereology Service, Teaching Hospitals of
University of Coimbra (Universidade de Coimbra, EPE) - Coimbra, Portugal</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES </title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pereira</surname>
              <given-names>LC</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Urticaria medicamentosa</article-title>
          <source>An Bras Dermatol</source>
          <year>1968</year>
          <volume>43</volume>
          <fpage>267</fpage>
          <lpage>271</lpage>
          <pub-id pub-id-type="pmid">4247500</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heinzerling</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Raile</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Rochlitz</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Zuberbier</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Worm</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Insulin allergy: clinical manifestations and management
strategies</article-title>
          <source>Allergy</source>
          <year>2008</year>
          <volume>63</volume>
          <fpage>148</fpage>
          <lpage>155</lpage>
          <pub-id pub-id-type="pmid">18186805</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wessbecher</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kiehn</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Stoffel</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Moll</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Management of insulin allergy</article-title>
          <source>Allergy</source>
          <year>2001</year>
          <volume>56</volume>
          <fpage>919</fpage>
          <lpage>920</lpage>
          <pub-id pub-id-type="pmid">11551264</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scheer</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Sitz</surname>
              <given-names>KV</given-names>
            </name>
          </person-group>
          <article-title>Suspected insulin anaphylaxis and literature review</article-title>
          <source>J Ark Med Soc</source>
          <year>2001</year>
          <volume>97</volume>
          <fpage>311</fpage>
          <lpage>313</lpage>
          <pub-id pub-id-type="pmid">11233502</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pf&#xF6;hler</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>M&#xFC;ller</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Hasselmann</surname>
              <given-names>DO</given-names>
            </name>
            <name>
              <surname>Tilgen</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Successful desensitization with human insulin in a patient with an
insulin allergy and hypersensitivity to protamine: a case report</article-title>
          <source>J Med Case Reports</source>
          <year>2008</year>
          <volume>2</volume>
          <fpage>283</fpage>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barranco</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Herrero</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tornero</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Barrio</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Frutos</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rodr&#xED;guez</surname>
              <given-names>A</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Systemic allergic reaction by a human insulin analog</article-title>
          <source>Allergy</source>
          <year>2003</year>
          <volume>58</volume>
          <fpage>536</fpage>
          <lpage>537</lpage>
          <pub-id pub-id-type="pmid">12757463</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Durand-Gonzalez</surname>
              <given-names>KN</given-names>
            </name>
            <name>
              <surname>Guillausseau</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Pecquet</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gayno</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>Glargine insulin is not an alternative in insulin
allergy</article-title>
          <source>Diabetes Care</source>
          <year>2003</year>
          <volume>36</volume>
          <fpage>2216</fpage>
          <pub-id pub-id-type="pmid">12832347</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Caruso</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Alonzi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gaeta</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Viola</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Romano</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Same-patient allergy to ampicillin and human insulin</article-title>
          <source>Allergy</source>
          <year>2009</year>
          <volume>64</volume>
          <fpage>1105</fpage>
          <lpage>1107</lpage>
          <pub-id pub-id-type="pmid">19243358</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jegasothy</surname>
              <given-names>BV</given-names>
            </name>
          </person-group>
          <article-title>Allergic reactions to insulin</article-title>
          <source>Int J Dermatol</source>
          <year>1980</year>
          <volume>19</volume>
          <fpage>139</fpage>
          <lpage>141</lpage>
          <pub-id pub-id-type="pmid">6993380</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
